[PRNewswire] Zymo Research Receives CE IVD Mark for its EZ DNA
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
Methylation-Lightning Kit
-- Proven bisulfite technology ideal for clinical applications
(IRVINE, Calif., Sept. 23, 2021 PRNewswire=연합뉴스) Today Zymo Research announced its EZ DNA Methylation-Lightning Kit™ [https://www.zymoresearch.com/products/ez-dna-methylation-lightning-kit?utm_source=PR+Newswire&utm_medium=press_release&utm_campaign=Lightning_CE_Press_Release_9.23.21 ] has received the CE IVD Mark allowing the technology to be distributed within the European Union (EU) common market. Chemical treatment of DNA with bisulfite is the prerequisite for many methylation-based diagnostic assays. Clinical diagnostic and screening tests, particularly those for cancer and developmental diseases, are now utilizing methylation profiling of DNA to detect the presence of disease and guide treatment.
The established, proven bisulfite-treatment chemistry from Zymo Research has been highly successful with clinical samples due to its robust and efficient (C)ytosine to (U)rasil conversion chemistry that also minimizes DNA fragmentation and degradation during the process. Desulphonation and cleanup of "converted DNA" are performed using a unique spin technology, allowing ultra-low elution (10 μl) volumes. The kit achieves the highest conversion efficiencies for the most accurate downstream methylation analysis. The EZ DNA Methylation-Lightning Kit features a ready-to-use conversion reagent, which streamlines the workflow for completion in a little over an hour. The kit is available in spin-column and high-throughput 96-well formats.
"The scientists at Zymo Research are always working to streamline and simplify workflows for our customers. The EZ DNA Methylation-Lightning Kit is one example of this philosophy," said Marc Van Eden, Zymo Research's Vice President of Business Development. "The kit consolidates many of the labor-intensive steps required for precise, complete bisulfite conversion of DNA making an otherwise cumbersome workflow user-friendly and consistent time after time. This is particularly critical for assay reproducibility in sensitive analytical processes such as Next-Gen sequencing."
For more information about the EZ DNA Methylation-Lightning Kit, visit Zymo Research's website [https://www.zymoresearch.com/products/ez-dna-methylation-lightning-kit?utm_source=PR+Newswire&utm_medium=press_release&utm_campaign=Lightning_CE_Press_Release_9.23.21 ].
About Zymo Research Corp.
Zymo Research is a privately owned company that has been serving the scientific and diagnostics community with state-of-the-art molecular biology tools since 1994. The company's vision "The Beauty of Science is to Make Things Simple" is reflected in all of their products, from epigenetics to DNA/RNA purification technologies. Historically recognized as the leader in epigenetics, Zymo Research is breaking boundaries with novel solutions for sample collection, microbiomic measurements, diagnostic devices, and NGS technologies that are high quality and simple to use. Follow Zymo Research on Facebook [https://www.facebook.com/zymoresearch ], LinkedIn [https://www.linkedin.com/company/zymo-research-corp/ ], Twitter [https://twitter.com/ZymoResearch ], and Instagram [https://www.instagram.com/zymoresearch/ ].
Logo - https://mma.prnewswire.com/media/364743/Zymo_Research_Corp_Logo.jpg
Zymo Research Corp. Logo
Source: Zymo Research Corp.
[편집자 주] 본고는 자료 제공사에서 제공한 것으로, 연합뉴스는 내용에 대해 어떠한 편집도 하지 않았음을 밝혀 드립니다.
(끝)
출처 : PRNewswire 보도자료
Copyright © 연합뉴스 보도자료. 무단전재 및 재배포 금지.
- 美, 중국산 전기차 관세 25→100%·태양전지 25→50%로 대폭인상 | 연합뉴스
- 의사 평균 연봉 3억원 넘었다…정부 "수급 부족 탓" | 연합뉴스
- 대통령실 "라인야후 보고서에 네이버 지분매각 포함 안 될 것(종합) | 연합뉴스
- 尹대통령, 젤렌스키 우크라 대통령과 통화…"지원·협력 계속" | 연합뉴스
- 이원석 "인사는 인사, 수사는 수사…어느 검사장 와도 원칙대로"(종합2보) | 연합뉴스
- 與주류, '김여사 방탄공세' 일축…유승민 "영원히 덮을순 없어"(종합) | 연합뉴스
- [아프리카를 가다] ④ K드라마에 태권도…보츠와나서 한류 바람 | 연합뉴스
- USTR "對중국 관세 부과 이후 한국 반도체 등이 중국산 대체" | 연합뉴스
- 與전대 최대변수 떠오른 한동훈…총선 책임론 공방도 가열(종합) | 연합뉴스
- 진성준 "전국민 25만원法, 당론 발의…與와 선별지급 협의 가능" | 연합뉴스